April 19, 2017 Monthly Meeting

1.) Identify at-risk patients, confirm the HCV type (and subtype), and obtain the viral load.
2.) Assess the severity of liver disease to determine appropriate care.
3.) Consider direct-acting antivirals in the era of interferon-free therapy